Gene · 10658
Papers1,641
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,641
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CIZ1 in Xist seeded assemblies at the inactive X chromosome. | Front Cell Dev Biol | 2023 | 38155839 | PubTator, text mining | PubMed |
| RNA-binding proteins regulating the CD44 alternative splicing. | Front Mol Biosci | 2023 | 38106992 | PubTator, text mining | PubMed |
| Transcriptome reprogramming through alternative splicing triggered by apigenin drives cell death in triple-negative breast cancer. | Cell Death Dis | 2023 | 38092740 | PubTator, text mining | PubMed |
| Long non-coding RNA and Evolving drug resistance in lung cancer. | Heliyon | 2023 | 38089985 | PubTator, text mining | PubMed |
| Neurogenetics and Epigenetics of Loneliness. | Psychol Res Behav Manag | 2023 | 38050640 | PubTator, text mining | PubMed |
| Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathways. | Sci Rep | 2023 | 38036593 | PubTator, text mining | PubMed |
| Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome. | Mol Ther Nucleic Acids | 2023 | 38028201 | PubTator, text mining | PubMed |
| Relationship Between FERMT2, CELF1, COPI, CHRNA2, and ABCA7 Genetic Polymorphisms and Alzheimer's Disease Risk in the Southern Chinese Population. | J Alzheimers Dis Rep | 2023 | 38025799 | PubTator, text mining | PubMed |
| A dual role of RBM42 in modulating splicing and translation of CDKN1A/p21 during DNA damage response. | Nat Commun | 2023 | 37993446 | PubTator, text mining | PubMed |
| m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling. | J Exp Clin Cancer Res | 2023 | 37986103 | PubTator, text mining | PubMed |
| Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. | Cancer Cell Int | 2023 | 37986065 | PubTator, text mining | PubMed |
| Changes in ADAR RNA editing patterns in CMV and ZIKV congenital infections. | BMC Genomics | 2023 | 37968596 | PubTator, text mining | PubMed |
| Glaucoma as a Tauopathy-Is It the Missing Piece in the Glaucoma Puzzle? | J Clin Med | 2023 | 37959365 | PubTator, text mining | PubMed |
| CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3. | Cancers (Basel) | 2023 | 37894405 | PubTator, text mining | PubMed |
| RNA modification in cardiovascular disease: implications for therapeutic interventions. | Signal Transduct Target Ther | 2023 | 37884527 | PubTator, text mining | PubMed |
| Long non-coding RNA generated from CDKN1A gene by alternative polyadenylation regulates p21 expression during DNA damage response. | Nucleic Acids Res | 2023 | 37870464 | PubTator, text mining | PubMed |
| Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance. | Int J Mol Sci | 2023 | 37834454 | PubTator, text mining | PubMed |
| Evaluation of the Polygenic Risk Score for Alzheimer's Disease in Russian Patients with Dementia Using a Low-Density Hydrogel Oligonucleotide Microarray. | Int J Mol Sci | 2023 | 37834213 | PubTator, text mining | PubMed |
| Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances. | J Transl Med | 2023 | 37814303 | PubTator, text mining | PubMed |
| Analyzing alternative splicing in Alzheimer's disease postmortem brain: a cell-level perspective. | Front Mol Neurosci | 2023 | 37799732 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10658/papers?page=4